Similar articles

• [Contraception with the intrauterine pessary: risk of pelvic inflammatory disease].

  Alder C, Bitzer J, Stöcklin M, Mall-Häfeli M. Alder C, et al. Ther Umsch. 1984 Jul;41(7):502-5. Ther Umsch. 1984. PMID: 6484876 German. No abstract available.
• Pelvic inflammatory disease and the Dalkon Shield.

  Edelman DA, Berger GS, Keith L. Edelman DA, et al. Obstet Gynecol. 1984 Aug;64(2):297-300. Obstet Gynecol. 1984. PMID: 6738964 No abstract available.
• Type of intrauterine device and the risk of pelvic inflammatory disease.

  Lee NC, Rubin GL, Ory HW, Burkman RT. Lee NC, et al. Obstet Gynecol. 1983 Jul;62(1):1-6. Obstet Gynecol. 1983. PMID: 6856209
• Infection risk and intrauterine devices.

  Martínez F, López-Arregui E. Martínez F, et al. Acta Obstet Gynecol Scand. 2009;88(3):246-50. doi: 10.1080/00016340802707473. Acta Obstet Gynecol Scand. 2009. PMID: 19172421 Review.
• Intrauterine contraception: current evidence-based recommendations.

  Kelly EK, Rudinsky SW. Kelly EK, et al. J Midwifery Womens Health. 2007 Sep-Oct;52(5):505-7. doi: 10.1016/j.jmwh.2006.08.014. J Midwifery Womens Health. 2007. PMID: 17826715 Review. No abstract available.